Introduction: A Drug Class That Redefined an Industry Very few pharmaceutical innovations have managed to simultaneously reshape clinical practice, redefine commercial markets, and establish new benchmarks in intellectual property strategy. GLP-1 receptor

Artificial intelligence has rapidly entered the world of intellectual property, promising to transform how patents are searched, analyzed, drafted, and even litigated. From automated prior art searches to AI-assisted claim drafting, the narrative is

In the world of patents, finality has always been a cornerstone of certainty. Once a patent is examined, challenged, and upheld, it is expected to provide a degree of stability—allowing innovators to move forward with confidence. But what happens when that

For years, global innovation leadership has been concentrated in a handful of regions—most notably the United States, Europe, and China. Patent filings, often used as a proxy for innovation strength, have historically reflected this distribution. But recent

Every breakthrough technology begins with an idea—often in a research lab, a university setting, or within the R&D division of a forward-thinking company. In its earliest form, that idea is raw, experimental, and uncertain. But as it evolves, it follows

Innovation has always been a marker of progress—but in today’s interconnected world, it has also become a measure of power. Nations and corporations are no longer competing solely on products or services; they are competing on who leads the innovation